NO20004271D0 - Benzylpiperazinyl and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine D4 receptor antagonists - Google Patents
Benzylpiperazinyl and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine D4 receptor antagonistsInfo
- Publication number
- NO20004271D0 NO20004271D0 NO20004271A NO20004271A NO20004271D0 NO 20004271 D0 NO20004271 D0 NO 20004271D0 NO 20004271 A NO20004271 A NO 20004271A NO 20004271 A NO20004271 A NO 20004271A NO 20004271 D0 NO20004271 D0 NO 20004271D0
- Authority
- NO
- Norway
- Prior art keywords
- benzylpiperidinyl
- benzylpiperazinyl
- dopamine
- preparation
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/54—Spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3098798A | 1998-02-26 | 1998-02-26 | |
PCT/US1999/004309 WO1999043670A1 (en) | 1998-02-26 | 1999-02-26 | Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20004271D0 true NO20004271D0 (en) | 2000-08-25 |
NO20004271L NO20004271L (en) | 2000-10-25 |
Family
ID=21857045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004271A NO20004271L (en) | 1998-02-26 | 2000-08-25 | Benzylpiperazinyl and benzylpiperidinylethanone derivatives, their preparation and their use as dopamine D4 receptor antagonists |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1068193A1 (en) |
JP (1) | JP2002504549A (en) |
KR (1) | KR20010041341A (en) |
CN (1) | CN1293669A (en) |
AU (1) | AU2881499A (en) |
CA (1) | CA2321830A1 (en) |
HU (1) | HUP0100926A3 (en) |
IL (1) | IL137930A0 (en) |
NO (1) | NO20004271L (en) |
PL (1) | PL342597A1 (en) |
WO (1) | WO1999043670A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6084098A (en) | 1999-02-26 | 2000-07-04 | Neurogen Corporation | Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
US6355644B1 (en) | 1999-06-14 | 2002-03-12 | Neurogen Corporation | Benzylpiperazinyl-indolinylethanones |
AU5487300A (en) * | 1999-06-14 | 2001-01-02 | Neurogen Corporation | Benzylpiperazinyl-indolinylethanones |
EP1177792A3 (en) | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
KR100394086B1 (en) | 2000-12-04 | 2003-08-06 | 한국과학기술연구원 | Novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 and D4 receptors, and preparation thereof |
KR100394083B1 (en) | 2000-12-04 | 2003-08-06 | 학교법인 성신학원 | Novel 4,5-dihydroisoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 and D4 receptors, and preparation thereof |
CN1181065C (en) * | 2002-05-08 | 2004-12-22 | 上海医药工业研究院 | Aralkylformylalkyl piperazine derivative and its application as brain nerve protector |
DE102004027358A1 (en) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidine compounds and their use |
GB201106817D0 (en) * | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
EP3071203B1 (en) | 2013-11-18 | 2020-12-23 | Forma Therapeutics, Inc. | Tetrahydroquinoline compositions as bet bromodomain inhibitors |
WO2015074081A1 (en) | 2013-11-18 | 2015-05-21 | Bair Kenneth W | Benzopiperazine compositions as bet bromodomain inhibitors |
AU2014369446C1 (en) | 2013-12-20 | 2020-03-12 | Astex Therapeutics Limited | Bicyclic heterocycle compounds and their uses in therapy |
CN103966340B (en) * | 2014-05-26 | 2015-09-16 | 宁波大学 | A kind of detection kit for auxiliary diagnosis alzheimer's disease and application thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2863752A (en) * | 1953-10-30 | 1958-12-09 | Monsanto Chemicals | Herbicides |
US2909523A (en) * | 1957-10-11 | 1959-10-20 | American Cyanamid Co | Substituted piperazines and method of preparing the same |
US3268584A (en) * | 1961-08-28 | 1966-08-23 | Monsanto Co | Herbicidal alpha-haloacetanilides |
GB1065801A (en) * | 1964-02-19 | 1967-04-19 | Nippon Soda Co | N-substituted fluoroacetamides and their use as insecticides |
DE2604224A1 (en) * | 1976-02-04 | 1977-08-11 | Hoechst Ag | HERBICIDAL AGENTS |
JPS5318540A (en) * | 1976-08-02 | 1978-02-20 | Nippon Nohyaku Co Ltd | Alpha-chloroacetamides and their use |
HU201757B (en) * | 1988-03-11 | 1990-12-28 | Pfizer | Process for producing pyrroloquinoline-, acridine-, benzoxazine-, benzthiazine-, indolobenzoxazine-, benzazepine and pyrrolophenothiazine carboxamides and pharmaceutical compositions comprising same |
EP0934932A4 (en) * | 1996-08-22 | 2002-06-26 | Meiji Seika Kaisha | Quinoline derivatives and psychotropic agent |
AU4455397A (en) * | 1996-08-23 | 1998-03-06 | Neurosearch A/S | Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists |
WO1998037064A1 (en) * | 1997-02-19 | 1998-08-27 | Hoechst Marion Roussel, Inc. | Benzamides having dopamine d4 receptor affinity |
AU1122399A (en) * | 1997-10-27 | 1999-05-17 | Neurogen Corporation | Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
JP2001521935A (en) * | 1997-10-31 | 2001-11-13 | ニューロゲン コーポレイション | 3-aminoalkylamino-2H-1,4-benzoxyazine and 3-aminoalkylamino-2H-1,4-benzothiazine: ligands specific to dopamine receptor subtypes |
-
1999
- 1999-02-26 AU AU28814/99A patent/AU2881499A/en not_active Abandoned
- 1999-02-26 PL PL99342597A patent/PL342597A1/en not_active Application Discontinuation
- 1999-02-26 CA CA002321830A patent/CA2321830A1/en not_active Abandoned
- 1999-02-26 JP JP2000533426A patent/JP2002504549A/en active Pending
- 1999-02-26 WO PCT/US1999/004309 patent/WO1999043670A1/en not_active Application Discontinuation
- 1999-02-26 EP EP99909657A patent/EP1068193A1/en not_active Withdrawn
- 1999-02-26 HU HU0100926A patent/HUP0100926A3/en unknown
- 1999-02-26 KR KR1020007009454A patent/KR20010041341A/en not_active Application Discontinuation
- 1999-02-26 IL IL13793099A patent/IL137930A0/en unknown
- 1999-02-26 CN CN99804026A patent/CN1293669A/en active Pending
-
2000
- 2000-08-25 NO NO20004271A patent/NO20004271L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010041341A (en) | 2001-05-15 |
EP1068193A1 (en) | 2001-01-17 |
HUP0100926A2 (en) | 2001-09-28 |
WO1999043670A1 (en) | 1999-09-02 |
CA2321830A1 (en) | 1999-09-02 |
IL137930A0 (en) | 2001-10-31 |
NO20004271L (en) | 2000-10-25 |
AU2881499A (en) | 1999-09-15 |
PL342597A1 (en) | 2001-06-18 |
JP2002504549A (en) | 2002-02-12 |
HUP0100926A3 (en) | 2003-03-28 |
CN1293669A (en) | 2001-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021719D0 (en) | 6-position substituted indolines, preparation and use thereof as a drug | |
NO20015113D0 (en) | New compounds, their preparation and use | |
NO20052995D0 (en) | 1,5-diaryl-pyrrole-3-carboxamide derivatives, and their use as cannabinoid receptor modulators. | |
NO20024749D0 (en) | Indolin-2-one derivatives, their preparation and use as ocytocin receptor ligands | |
NO20015156L (en) | 5-pyridyl-1,3-azole compounds, their preparation and use | |
NO20006029L (en) | Pyrazoline derivatives, their preparation and use as pharmaceuticals | |
DK1095025T3 (en) | Benzimidazoles, their preparation and their use as drugs | |
NO20014603L (en) | Tienopyrimidine Compounds, Their Preparation and Use | |
NO20031952L (en) | 3-aroylin derivatives and their use as CB2 receptor agonists | |
NO20012567D0 (en) | Azepinoindole derivatives, preparation and use thereof | |
NO20020314L (en) | 2-arylimino-2,3-dihydrotiazoles and their use as ligands for somatostatin receptors | |
NO20015362L (en) | Heterocyclic substituted benzimidazoles, their preparation and use thereof | |
NO20011503L (en) | Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, their preparation and use as anorectic drugs | |
NO20006138L (en) | Substituted indolinones, preparation and use thereof as medicaments | |
NO20005146D0 (en) | Thienylazolylalkoxyethanamines, their preparation and their use as drugs | |
NO20004271D0 (en) | Benzylpiperazinyl and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine D4 receptor antagonists | |
NO20023146L (en) | Substituted phenyl-piperazine derivatives, their preparation and use | |
DK1043307T3 (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use | |
NO20004144D0 (en) | Heterocyclic compounds, their preparation and use as tachykinin receptor antagonists | |
DK1189932T3 (en) | New Echinocandin Derivatives, Methods for their Preparation and their Use as Antifungal Agents | |
NO20001937D0 (en) | 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5-HT1B and 5-HT1D) | |
NO20012802D0 (en) | Benzofuran derivatives, their preparation and use | |
NO20001782L (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use | |
NO20022455D0 (en) | Sulfonyloxazolamines and their use as 5-HT6 receptor ligands | |
DK1010689T3 (en) | Substituted cycloheptenes, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |